Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology of Parkinson's Disease—East Versus West
Masoom M. Abbas, Zheyu Xu, Louis C.S. Tan
Movement Disorders Clinical Practice (2017) Vol. 5, Iss. 1, pp. 14-28
Open Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Parkinson’s Disease: A Review from Pathophysiology to Treatment
Bianca L. B. Marino, Lucilene Rocha de Souza, Kessia P.A. Sousa, et al.
Mini-Reviews in Medicinal Chemistry (2019) Vol. 20, Iss. 9, pp. 754-767
Closed Access | Times Cited: 174
Sex differences in movement disorders
Sara Meoni, Antonella Macerollo, Elena Moro
Nature Reviews Neurology (2020) Vol. 16, Iss. 2, pp. 84-96
Closed Access | Times Cited: 163
Parkinson's disease in the Western Pacific Region
Shen‐Yang Lim, Ai Huey Tan, Azlina Ahmad‐Annuar, et al.
The Lancet Neurology (2019) Vol. 18, Iss. 9, pp. 865-879
Closed Access | Times Cited: 158
Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline From the American Physical Therapy Association
Jacqueline A Osborne, Rachel Botkin, Cristina Colón-Semenza, et al.
Physical Therapy (2021) Vol. 102, Iss. 4
Open Access | Times Cited: 124
Role of Alcohol Drinking in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis
Bin Peng, Qiang Yang, Rachna B Joshi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2316-2316
Open Access | Times Cited: 123
Ethnic Variation in the Manifestation of Parkinson’s Disease: A Narrative Review
Aaron Ben-Joseph, Charles R. Marshall, Andrew J. Lees, et al.
Journal of Parkinson s Disease (2019) Vol. 10, Iss. 1, pp. 31-45
Open Access | Times Cited: 110
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
Upasana Ganguly, Sukhpal Singh, Soumya Pal, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 96
MicroRNA Dysregulation in Parkinson’s Disease: A Narrative Review
Yong Hui Nies, Nor Haliza Mohamad Najib, Wei Ling Lim, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 77
Unmet Needs of Women Living with Parkinson's Disease: Gaps and Controversies
Indu Subramanian, Soania Mathur, Annelien Oosterbaan, et al.
Movement Disorders (2022) Vol. 37, Iss. 3, pp. 444-455
Closed Access | Times Cited: 66
A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population
Brage Brakedal, Lilah Toker, Kristoffer Haugarvoll, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 63
Mitophagy and reactive oxygen species interplay in Parkinson’s disease
Bin Xiao, Joshua Kuruvilla, Eng‐King Tan
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 51
Update: Descriptive epidemiology of Parkinson disease
Nikolas Grotewold, Roger L. Albin
Parkinsonism & Related Disorders (2024) Vol. 120, pp. 106000-106000
Closed Access | Times Cited: 15
The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease: A Promising Therapeutic Approach
Y. So, Jae-Ung Lee, Ga-Seung Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1071-1071
Open Access | Times Cited: 11
A systematic review and meta-analysis of the prevalence of Parkinson’s disease in lower to upper-middle-income countries
Gabriela Magalhães Pereira, Daniel Teixeira dos Santos, Nayron Medeiros Soares, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Selenium and Other Trace Elements in the Etiology of Parkinson’s Disease: A Systematic Review and Meta-Analysis of Case-Control Studies
Giorgia Adani, Tommaso Filippini, Bernhard Michalke, et al.
Neuroepidemiology (2019) Vol. 54, Iss. 1, pp. 1-23
Open Access | Times Cited: 71
Targeting the Dopaminergic System in Autoimmunity
Pía M. Vidal, Rodrigo Pacheco
Journal of Neuroimmune Pharmacology (2019) Vol. 15, Iss. 1, pp. 57-73
Closed Access | Times Cited: 69
Association of statin use with Parkinson's disease: Dose–response relationship
Su‐Min Jeong, Woo Young Jang, Dong Wook Shin
Movement Disorders (2019) Vol. 34, Iss. 7, pp. 1014-1021
Closed Access | Times Cited: 57
Parkinson's Disease: Risk Factor Modification and Prevention
Suraj Rajan, Bonnie Kaas
Seminars in Neurology (2022) Vol. 42, Iss. 05, pp. 626-638
Closed Access | Times Cited: 36
Mild cognitive impairment in patients with Parkinson’s disease: An updated mini-review and future outlook
Rwei‐Ling Yu, Ruey‐Meei Wu
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 31
Old problems, new solutions: harnessing technology and innovation in Parkinson’s disease—evidence and experiences from Thailand
Roongroj Bhidayasiri
Journal of Neural Transmission (2024) Vol. 131, Iss. 6, pp. 721-738
Closed Access | Times Cited: 8
Enhancing selegiline hydrochloride efficacy: Box Behnken-optimized liposomal delivery via intranasal route for Parkinson’s disease intervention
Kartik Bhairu Khot, D S Sandeep, Gopika Gopan, et al.
Journal of Liposome Research (2024), pp. 1-18
Closed Access | Times Cited: 7
Guidelines on exercise testing and prescription for patients at different stages of Parkinson’s disease
Camilla Martignon, Anna Pedrinolla, Federico Ruzzante, et al.
Aging Clinical and Experimental Research (2020) Vol. 33, Iss. 2, pp. 221-246
Closed Access | Times Cited: 47
Gender differences in motor and non-motor symptoms in early Parkinson disease
Kyung Wook Kang, Seong‐Min Choi, Byeong C. Kim
Medicine (2022) Vol. 101, Iss. 3, pp. e28643-e28643
Open Access | Times Cited: 28
Potential Role of Heterocyclic Aromatic Amines in Neurodegeneration
Tauqeerunnisa Syeda, Jason R. Cannon
Chemical Research in Toxicology (2022) Vol. 35, Iss. 1, pp. 59-72
Open Access | Times Cited: 23
Single-cell transcriptomics of human iPSC differentiation dynamics reveal a core molecular network of Parkinson’s disease
Gabriela Novak, Dimitrios Kyriakis, Kamil Grzyb, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top